Hill-Rom Holdings (NYSE:HRC) said today that it agreed to put up $250 million in cash for the operating room infrastructure arm of Germany’s Trumpf Group.
Wall Street Beat
Blockbuster: Medtronic in $43B deal to acquire Covidien
Ackman takes Allergan to court to defend against ‘poison pill’
European Commission tables review of Zimmer’s $13B acquisition of Biomet
Bard announces $500M buyback
C.R. Bard (NYSE:BCR) said it plans to buy back as much as $500 million worth of its own stock, having spent all but $30 million of a prior share repurchasing plan also worth half a billion.
Companies often buy back their stock when they believe the market is undervaluing share prices, in an effort to raise the price.
Medtronic, Johnson & Johnson store billions in cash in overseas subsidiaries | Medtech Wall Street news for the week of June 9, 2014
Convicted ex-Heart Tronics lawyer won’t get a retrial, judge rules
A California District Judge harshly refused former Signalife and Heart Tronics lawyer Mitchell Stein’s motion for a retrial, taking offense to the request itself.
Allergan board members unanimously reject Valeant’s $53B offer
Philips, Teva ink Israeli medtech incubator JV
Medtronic, Johnson & Johnson park billions in offshore accounts
There are no awards handed out for companies with the most money housed in overseas accounts, but keeping cash in tax havens is its own reward for at least a dozen top medical device makers, according to a new study.
Stryker evaluates acquisition of orthopedics rival Smith & Nephew | Medtech Wall Street news for the week of June 2, 2014
What if Stryker bought Smith & Nephew?
May 29, 2014 by Brad Perriello
Stryker CEO Kevin Lobo yesterday admitted that his company was evaluating an acquisition of British orthopedics rival Smith & Nephew.